P61077 (UB2D3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 103.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ubiquitin-conjugating enzyme E2 D3 EC=6.3.2.19 Alternative name(s): Ubiquitin carrier protein D3 Ubiquitin-conjugating enzyme E2(17)KB 3 Ubiquitin-conjugating enzyme E2-17 kDa 3 Ubiquitin-protein ligase D3 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 147 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'-linked polyubiquitination. Cooperates with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Ubiquitin chain elongation is then performed by CDC34, building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. Acts also as an initiator E2, in conjunction with RNF8, for the priming of PCNA. Monoubiquitination of PCNA, and its subsequent polyubiquitination, are essential events in the operation of the DNA damage tolerance (DDT) pathway that is activated after DNA damage caused by UV or chemical agents during S-phase. Associates with the BRCA1/BARD1 E3 ligase complex to perform ubiquitination at DNA damage sites following ionizing radiation leading to DNA repair. Targets DAPK3 for ubiquitination which influences promyelocytic leukemia protein nuclear body (PML-NB) formation in the nucleus. In conjunction with the MDM2 and TOPORS E3 ligases, functions ubiquitination of p53/TP53. Supports NRDP1-mediated ubiquitination and degradation of ERBB3 and of BRUCE which triggers apoptosis. In conjunction with the CBL E3 ligase, targets EGFR for polyubiquitination at the plasma membrane as well as during its internalization and transport on endosomes. In conjunction with the STUB1 E3 quality control E3 ligase, ubiquitinates unfolded proteins to catalyze their immediate destruction By similarity. Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.19 Ref.20 Ref.21 Ref.23 |
| Catalytic activity | ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine. |
| Pathway | |
| Subunit structure | Interacts with SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex; when Cullin is neddylated, the interaction between the E2 and the SCF complex is strengthened. Interacts with DAPK3. Interacts with BRCA1; the DNA damage checkpoint promotes the association with BRCA1 after ionizing radiation. Interacts non-covalently with ubiquitin. Ref.14 Ref.15 Ref.18 Ref.24 |
| Subcellular location | Cell membrane; Peripheral membrane protein. Endosome membrane; Peripheral membrane protein Ref.17. |
| Sequence similarities | Belongs to the ubiquitin-conjugating enzyme family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| RNF11 | Q9Y3C5 | 3 | EBI-348268,EBI-396669 | |
| RNF126 | Q9BV68 | 3 | EBI-348268,EBI-357322 | |
| RNF43 | Q68DV7 | 2 | EBI-348268,EBI-1647060 | |
| RNF5 | Q99942 | 3 | EBI-348268,EBI-348482 | |
| TRAF6 | Q9Y4K3 | 2 | EBI-348268,EBI-359276 | |
| XIAP | P98170 | 2 | EBI-348268,EBI-517127 | |
| ZNRF1 | Q8ND25 | 3 | EBI-348268,EBI-2129250 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P61077-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P61077-2) The sequence of this isoform differs from the canonical sequence as follows: 134-147: YNRISREWTQKYAM → YNRLAREWTEKYAML | ||||||
| Isoform 3 (identifier: P61077-3) The sequence of this isoform differs from the canonical sequence as follows: 1-8: MALKRINK → MLSNRKCLSK |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 147 | 147 | Ubiquitin-conjugating enzyme E2 D3 | PRO_0000082466 | ||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||
| Active site | 85 | 1 | Glycyl thioester intermediate By similarity | |||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||
| Disulfide bond | 21 ↔ 107 | Ref.25 | ||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 8 | 8 | MALKRINK → MLSNRKCLSK in isoform 3. | VSP_038096 | ||||||||||||||||||||||||||||
| Alternative sequence | 134 – 147 | 14 | YNRIS…QKYAM → YNRLAREWTEKYAML in isoform 2. | VSP_038097 | ||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||
| Mutagenesis | 77 | 1 | N → S: Activity is restricted HECT-type and not RING-containing E3 ubiquitin-protein ligases. Exhibits ubiquitin transfer with ARIH1 and PARK2. Ref.23 | |||||||||||||||||||||||||||||
| Mutagenesis | 85 | 1 | C → A: Loss of function. Ref.8 | |||||||||||||||||||||||||||||
| Mutagenesis | 87 | 1 | D → E or P: Has intermediate lysine reactivity. Ref.23 | |||||||||||||||||||||||||||||
| Mutagenesis | 87 | 1 | D → K: Abolishes affect lysine reactivity. Ref.23 | |||||||||||||||||||||||||||||
| Mutagenesis | 87 | 1 | D → N: Does not affect lysine reactivity. Ref.23 | |||||||||||||||||||||||||||||
| Mutagenesis | 117 | 1 | D → H: Strongly impairs lysine reactivity but retains some ability to transfer ubiquitin to BRCA1. Ref.23 | |||||||||||||||||||||||||||||
| Sequence conflict | 50 | 1 | Missing in DB045280. Ref.3 | |||||||||||||||||||||||||||||
| Sequence conflict | 123 | 1 | I → L in AAH66917. Ref.7 | |||||||||||||||||||||||||||||
| Sequence conflict | 137 | 1 | I → V in CAG33197. Ref.3 | |||||||||||||||||||||||||||||
| Sequence conflict | 147 | 1 | M → I in CAG33197. Ref.3 | |||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||
| Helix | 1 – 15 | 15 | ||||||||||||||||||||||||||||||
| Beta strand | 21 – 26 | 6 | ||||||||||||||||||||||||||||||
| Beta strand | 32 – 38 | 7 | ||||||||||||||||||||||||||||||
| Beta strand | 41 – 43 | 3 | ||||||||||||||||||||||||||||||
| Turn | 44 – 47 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 49 – 55 | 7 | ||||||||||||||||||||||||||||||
| Turn | 58 – 61 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 66 – 69 | 4 | ||||||||||||||||||||||||||||||
| Helix | 87 – 89 | 3 | ||||||||||||||||||||||||||||||
| Turn | 90 – 92 | 3 | ||||||||||||||||||||||||||||||
| Helix | 99 – 111 | 13 | ||||||||||||||||||||||||||||||
| Helix | 121 – 129 | 9 | ||||||||||||||||||||||||||||||
| Helix | 131 – 145 | 15 | ||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification of a family of closely related human ubiquitin conjugating enzymes." Jensen J.P., Bates P.W., Yang M., Vierstra R.D., Weissman A.M. J. Biol. Chem. 270:30408-30414(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "Genome sequencing of the chromosome 4q region implicated in human hepatocellular carcinoma pathogenesis." Chang H.-M., Tsai S.-F. Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3). Tissue: Chondrocyte and Testis. |
| [4] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [5] | "Generation and annotation of the DNA sequences of human chromosomes 2 and 4." Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain and Placenta. |
| [8] | "Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha." Gonen H., Bercovich B., Orian A., Carrano A., Takizawa C., Yamanaka K., Pagano M., Iwai K., Ciechanover A. J. Biol. Chem. 274:14823-14830(1999) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF CYS-85. |
| [9] | "CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein." Murata S., Minami Y., Minami M., Chiba T., Tanaka K. EMBO Rep. 2:1133-1138(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "Mammalian Numb is a target protein of Mdm2, ubiquitin ligase." Yogosawa S., Miyauchi Y., Honda R., Tanaka H., Yasuda H. Biochem. Biophys. Res. Commun. 302:869-872(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [11] | "Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53." Rajendra R., Malegaonkar D., Pungaliya P., Marshall H., Rasheed Z., Brownell J., Liu L.F., Lutzker S., Saleem A., Rubin E.H. J. Biol. Chem. 279:36440-36444(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [12] | "Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo." Saville M.K., Sparks A., Xirodimas D.P., Wardrop J., Stevenson L.F., Bourdon J.C., Woods Y.L., Lane D.P. J. Biol. Chem. 279:42169-42181(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [13] | "The poxvirus p28 virulence factor is an E3 ubiquitin ligase." Huang J., Huang Q., Zhou X., Shen M.M., Yen A., Yu S.X., Dong G., Qu K., Huang P., Anderson E.M., Daniel-Issakani S., Buller R.M., Payan D.G., Lu H.H. J. Biol. Chem. 279:54110-54116(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [14] | "A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites." Polanowska J., Martin J.S., Garcia-Muse T., Petalcorin M.I.R., Boulton S.J. EMBO J. 25:2178-2188(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH BRCA1, FUNCTION. |
| [15] | "Physical and functional interactions between ZIP kinase and UbcH5." Ohbayashi N., Okada K., Kawakami S., Togi S., Sato N., Ikeda O., Kamitani S., Muromoto R., Sekine Y., Kawai T., Akira S., Matsuda T. Biochem. Biophys. Res. Commun. 372:708-712(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH DAPK3, FUNCTION. |
| [16] | "PCNA is ubiquitinated by RNF8." Zhang S., Chea J., Meng X., Zhou Y., Lee E.Y.C., Lee M.Y.W.T. Cell Cycle 7:3399-3404(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [17] | "Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation." Umebayashi K., Stenmark H., Yoshimori T. Mol. Biol. Cell 19:3454-3462(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [18] | "Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation." Saha A., Deshaies R.J. Mol. Cell 32:21-31(2008) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SCF COMPLEX. |
| [19] | "Legionella translocates an E3 ubiquitin ligase that has multiple U-boxes with distinct functions." Kubori T., Hyakutake A., Nagai H. Mol. Microbiol. 67:1307-1319(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [20] | "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines." David Y., Ziv T., Admon A., Navon A. J. Biol. Chem. 285:8595-8604(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [21] | "Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate." Wu K., Kovacev J., Pan Z.Q. Mol. Cell 37:784-796(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [22] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [23] | "UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids." Wenzel D.M., Lissounov A., Brzovic P.S., Klevit R.E. Nature 474:105-108(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ASN-77; ASP-87 AND ASP-117. |
| [24] | "A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination." Brzovic P.S., Lissounov A., Christensen D.E., Hoyt D.W., Klevit R.E. Mol. Cell 21:873-880(2006) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 2-147 IN COMPLEX WITH THE BRCA1/BARD1 RING-DOMAIN HETERODIMER, INTERACTION WITH BRCA1. |
| [25] | "Crystal structure of UBCH5C." Nakanishi M., Teshima N., Mizushima T., Murata S., Tanaka K., Yamane T. Submitted (FEB-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1-147, DISULFIDE BOND. |
| [26] | "Crystal structure of the U-Box domain of human e4b ubiquitin ligase in complex with UBCH5C E2 ubiquitin conjugating enzyme." Benirschke R., Thompson J.R., Mer G. Submitted (MAY-2010) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (3.17 ANGSTROMS) OF 1-147 IN COMPLEX WITH U-BOX DOMAIN OF UBE4B. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U39318 mRNA. Translation: AAA91461.1. AF213884 Genomic DNA. Translation: AAF35234.1. AK095822 mRNA. Translation: BAC04632.1. DB045280 mRNA. No translation available. CR456916 mRNA. Translation: CAG33197.1. AC018797 Genomic DNA. No translation available. CH471057 Genomic DNA. Translation: EAX06138.1. CH471057 Genomic DNA. Translation: EAX06143.1. BC003395 mRNA. Translation: AAH03395.1. BC037894 mRNA. Translation: AAH37894.1. BC066917 mRNA. Translation: AAH66917.1. | ||||||||||||||||||||||||||||||||||||
| IPI | IPI00026965. IPI00375142. IPI00749013. | ||||||||||||||||||||||||||||||||||||
| RefSeq | NP_003331.1. NM_003340.5. NP_871615.1. NM_181886.2. NP_871616.1. NM_181887.1. NP_871617.1. NM_181888.2. NP_871618.1. NM_181889.1. NP_871619.1. NM_181890.1. NP_871620.1. NM_181891.1. NP_871621.1. NM_181892.2. NP_871622.1. NM_181893.1. | ||||||||||||||||||||||||||||||||||||
| UniGene | Hs.518773. | ||||||||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||||||||
| ProteinModelPortal | P61077. | ||||||||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||||||||
| DIP | DIP-29062N. | ||||||||||||||||||||||||||||||||||||
| IntAct | P61077. 79 interactions. | ||||||||||||||||||||||||||||||||||||
| MINT | MINT-1032046. | ||||||||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000349722. | ||||||||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||||||||
| PhosphoSite | P61077. | ||||||||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||||||||
| DMDM | 46577654. | ||||||||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||||||||
| PRIDE | P61077. | ||||||||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||||||||
| Ensembl | ENST00000321805; ENSP00000318494; ENSG00000109332. ENST00000338145; ENSP00000337208; ENSG00000109332. ENST00000343106; ENSP00000345285; ENSG00000109332. ENST00000349311; ENSP00000344069; ENSG00000109332. ENST00000357194; ENSP00000349722; ENSG00000109332. ENST00000394801; ENSP00000378280; ENSG00000109332. ENST00000394803; ENSP00000378282; ENSG00000109332. ENST00000394804; ENSP00000378283; ENSG00000109332. ENST00000453744; ENSP00000396901; ENSG00000109332. | ||||||||||||||||||||||||||||||||||||
| GeneID | 7323. | ||||||||||||||||||||||||||||||||||||
| KEGG | hsa:7323. | ||||||||||||||||||||||||||||||||||||
| UCSC | uc003hwi.3. human. uc003hwk.3. human. uc003hwq.3. human. | ||||||||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||||||||
| CTD | 7323. | ||||||||||||||||||||||||||||||||||||
| GeneCards | GC04M103717. | ||||||||||||||||||||||||||||||||||||
| HGNC | HGNC:12476. UBE2D3. | ||||||||||||||||||||||||||||||||||||
| HPA | HPA003920. | ||||||||||||||||||||||||||||||||||||
| MIM | 602963. gene. | ||||||||||||||||||||||||||||||||||||
| neXtProt | NX_P61077. | ||||||||||||||||||||||||||||||||||||
| PharmGKB | PA37126. | ||||||||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||||||||
| HOVERGEN | HBG063308. | ||||||||||||||||||||||||||||||||||||
| KO | K06689. | ||||||||||||||||||||||||||||||||||||
| OMA | DMSKDPP. | ||||||||||||||||||||||||||||||||||||
| OrthoDB | EOG4RR6JK. | ||||||||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | bard1pathway. BARD1 signaling events. nfkappabcanonicalpathway. Canonical NF-kappaB pathway. | ||||||||||||||||||||||||||||||||||||
| Reactome | REACT_107772. Immune System. REACT_111102. Signal Transduction. REACT_120956. Cellular responses to stress. REACT_6900. Immune System. REACT_71. Gene Expression. | ||||||||||||||||||||||||||||||||||||
| UniPathway | UPA00143. | ||||||||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||||||||
| ArrayExpress | P61077. | ||||||||||||||||||||||||||||||||||||
| Bgee | P61077. | ||||||||||||||||||||||||||||||||||||
| CleanEx | HS_UBE2D3. | ||||||||||||||||||||||||||||||||||||
| Genevestigator | P61077. | ||||||||||||||||||||||||||||||||||||
| GermOnline | ENSG00000109332. Homo sapiens. | ||||||||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||||||||
| Gene3D | 3.10.110.10. 1 hit. | ||||||||||||||||||||||||||||||||||||
| InterPro | IPR000608. UBQ-conjugat_E2. IPR023313. UBQ-conjugating_AS. IPR016135. UBQ-conjugating_enzyme/RWD. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| Pfam | PF00179. UQ_con. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| SUPFAM | SSF54495. UBQ-conjugat/RWD-like. 1 hit. | ||||||||||||||||||||||||||||||||||||
| PROSITE | PS00183. UBIQUITIN_CONJUGAT_1. 1 hit. PS50127. UBIQUITIN_CONJUGAT_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||||||||
| ChiTaRS | UBE2D3. human. | ||||||||||||||||||||||||||||||||||||
| EvolutionaryTrace | P61077. | ||||||||||||||||||||||||||||||||||||
| GenomeRNAi | 7323. | ||||||||||||||||||||||||||||||||||||
| NextBio | 28636. | ||||||||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||||||||
Entry information
| Entry name | UB2D3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P61077 Secondary accession number(s): A6NJ93 Q8N924 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 4 Human chromosome 4: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
